共 50 条
- [2] Response to “Comment on ‘Impact of TNF-α inhibitor on lipid profile and atherogenic index of plasma in axial spondyloarthritis: Two-year follow-up data from the Catholic Axial Spondyloarthritis COhort (CASCO)’” [J]. Clinical Rheumatology, 2020, 39 : 481 - 482
- [4] Impact of TNF-α inhibitor on lipid profile and atherogenic index of plasma in axial spondyloarthritis: 2-year follow-up data from the Catholic Axial Spondyloarthritis COhort (CASCO) [J]. Clinical Rheumatology, 2020, 39 : 471 - 477
- [6] Comment on “Impact of TNF-Α inhibitor on lipid profile and atherogenic index of plasma in axial spondyloarthritis: 2-year follow-up data from the catholic axial spondyloarthritis cohort (CASCO)” [J]. Clinical Rheumatology, 2020, 39 : 479 - 480
- [8] Predictors of Assessment of Spondyloarthritis International Society (ASAS) Health Index in Axial Spondyloarthritis and Comparison of ASAS Health Index between Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis: Data from the Catholic Axial Spondyloarthritis COhort (CASCO) [J]. JOURNAL OF CLINICAL MEDICINE, 2019, 8 (04):